Concepedia

Andrew L. Frelinger

AL

Statistics

Publications

113

Citations

10.5K

H-Index

52

Active since

1978

Affiliations

Harvard University(Current)

University of Massachusetts Chan Medical School

Boston Children's Hospital

Dana-Farber Cancer Institute

Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Andrew L. Frelinger is an author at Harvard University specializing in medicine, platelet function, and platelet physiology.

Publications per year

1978–2023

113

Publications

113

Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention

Stephen D. Wiviott, Dietmar Trenk, Andrew L. Frelinger et al. · Circulation · 2007 · 877 citations

Medicine, Pharmacology, Pharmacotherapy +17

Ligands “activate” integrin αIIbβ3 (platelet GPIIb-IIIa)

Xiaoping Du, Edward F. Plow, Andrew L. Frelinger et al. · Cell · 1991 · 490 citations

Life Sciences, Cell Biology, Molecular Biology +12

A β <sub>3</sub> Integrin Mutation Abolishes Ligand Binding and Alters Divalent Cation-Dependent Conformation

Joseph C. Loftus, Timothy E. O’Toole, Edward F. Plow et al. · Science · 1990 · 411 citations

Life Sciences, Biochemistry, Molecular Biology +17

Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction

Mark I. Furman, Marc R. Barnard, Lori A. Krueger et al. · Journal of the American College of Cardiology · 2001 · 406 citations

Medicine, Cardiology, Immunology +11

Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease

Jessica L. Mega, Willibald Hochholzer, Andrew L. Frelinger et al. · JAMA · 2011 · 376 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +17

1–5 of 113